The size and burden of mental disorders and other disorders of the brain in Europe 2010.

Aims: To provide 12-month prevalence and disability burden estimates of a broad range of mental and neurological disorders in the European Union (EU) and to compare these findings to previous estimates. Referring to our previous 2005 review, improved up-to-date data for the enlarged EU on a broader...

Full description

Bibliographic Details
Published in:European Neuropsychopharmacology
Main Authors: Wittchen, H.U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., Fratiglioni, L., Jennum, P., Lieb, R., Maercker, A., van Os, J., Preisig, M., Salvador-Carulla, L., Simon, R., Steinhausen, H.C.
Format: Article in Journal/Newspaper
Language:English
Published: 2011
Subjects:
Online Access:https://doi.org/10.1016/j.euroneuro.2011.07.018
https://serval.unil.ch/notice/serval:BIB_78A8797CC5B2
id fttriple:oai:gotriple.eu:10670/1.2akzd0
record_format openpolar
spelling fttriple:oai:gotriple.eu:10670/1.2akzd0 2023-05-15T16:52:33+02:00 The size and burden of mental disorders and other disorders of the brain in Europe 2010. Wittchen, H.U. Jacobi, F. Rehm, J. Gustavsson, A. Svensson, M. Jönsson, B. Olesen, J. Allgulander, C. Alonso, J. Faravelli, C. Fratiglioni, L. Jennum, P. Lieb, R. Maercker, A. van Os, J. Preisig, M. Salvador-Carulla, L. Simon, R. Steinhausen, H.C. 2011-01-01 https://doi.org/10.1016/j.euroneuro.2011.07.018 https://serval.unil.ch/notice/serval:BIB_78A8797CC5B2 en eng doi:10.1016/j.euroneuro.2011.07.018 urn:issn:0924-977X 10670/1.2akzd0 https://serval.unil.ch/notice/serval:BIB_78A8797CC5B2 undefined Serveur académique Lausannois European Neuropsychopharmacology, vol. 21, no. 9, pp. 655-79 demo hisphilso Journal Article https://vocabularies.coar-repositories.org/resource_types/c_6501/ 2011 fttriple https://doi.org/10.1016/j.euroneuro.2011.07.018 2023-01-22T17:45:41Z Aims: To provide 12-month prevalence and disability burden estimates of a broad range of mental and neurological disorders in the European Union (EU) and to compare these findings to previous estimates. Referring to our previous 2005 review, improved up-to-date data for the enlarged EU on a broader range of disorders than previously covered are needed for basic, clinical and public health research and policy decisions and to inform about the estimated number of persons affected in the EU. Method: Stepwise multi-method approach, consisting of systematic literature reviews, reanalyses of existing data sets, national surveys and expert consultations. Studies and data from all member states of the European Union (EU-27) plus Switzerland, Iceland and Norway were included. Supplementary information about neurological disorders is provided, although methodological constraints prohibited the derivation of overall prevalence estimates for mental and neurological disorders. Disease burden was measured by disability adjusted life years (DALY). Results: Prevalence: It is estimated that each year 38.2% of the EU population suffers from a mental disorder. Adjusted for age and comorbidity, this corresponds to 164.8 million persons affected. Compared to 2005 (27.4%) this higher estimate is entirely due to the inclusion of 14 new disorders also covering childhood/adolescence as well as the elderly. The estimated higher number of persons affected (2011: 165 m vs. 2005: 82 m) is due to coverage of childhood and old age populations, new disorders and of new EU membership states. The most frequent disorders are anxiety disorders (14.0%), insomnia (7.0%), major depression (6.9%), somatoform (6.3%), alcohol and drug dependence (>4%), ADHD (5%) in the young, and dementia (1-30%, depending on age). Except for substance use disorders and mental retardation, there were no substantial cultural or country variations. Although many sources, including national health insurance programs, reveal increases in sick leave, early retirement and ... Article in Journal/Newspaper Iceland Unknown Daly ENVELOPE(63.761,63.761,-67.513,-67.513) Norway European Neuropsychopharmacology 21 9 655 679
institution Open Polar
collection Unknown
op_collection_id fttriple
language English
topic demo
hisphilso
spellingShingle demo
hisphilso
Wittchen, H.U.
Jacobi, F.
Rehm, J.
Gustavsson, A.
Svensson, M.
Jönsson, B.
Olesen, J.
Allgulander, C.
Alonso, J.
Faravelli, C.
Fratiglioni, L.
Jennum, P.
Lieb, R.
Maercker, A.
van Os, J.
Preisig, M.
Salvador-Carulla, L.
Simon, R.
Steinhausen, H.C.
The size and burden of mental disorders and other disorders of the brain in Europe 2010.
topic_facet demo
hisphilso
description Aims: To provide 12-month prevalence and disability burden estimates of a broad range of mental and neurological disorders in the European Union (EU) and to compare these findings to previous estimates. Referring to our previous 2005 review, improved up-to-date data for the enlarged EU on a broader range of disorders than previously covered are needed for basic, clinical and public health research and policy decisions and to inform about the estimated number of persons affected in the EU. Method: Stepwise multi-method approach, consisting of systematic literature reviews, reanalyses of existing data sets, national surveys and expert consultations. Studies and data from all member states of the European Union (EU-27) plus Switzerland, Iceland and Norway were included. Supplementary information about neurological disorders is provided, although methodological constraints prohibited the derivation of overall prevalence estimates for mental and neurological disorders. Disease burden was measured by disability adjusted life years (DALY). Results: Prevalence: It is estimated that each year 38.2% of the EU population suffers from a mental disorder. Adjusted for age and comorbidity, this corresponds to 164.8 million persons affected. Compared to 2005 (27.4%) this higher estimate is entirely due to the inclusion of 14 new disorders also covering childhood/adolescence as well as the elderly. The estimated higher number of persons affected (2011: 165 m vs. 2005: 82 m) is due to coverage of childhood and old age populations, new disorders and of new EU membership states. The most frequent disorders are anxiety disorders (14.0%), insomnia (7.0%), major depression (6.9%), somatoform (6.3%), alcohol and drug dependence (>4%), ADHD (5%) in the young, and dementia (1-30%, depending on age). Except for substance use disorders and mental retardation, there were no substantial cultural or country variations. Although many sources, including national health insurance programs, reveal increases in sick leave, early retirement and ...
format Article in Journal/Newspaper
author Wittchen, H.U.
Jacobi, F.
Rehm, J.
Gustavsson, A.
Svensson, M.
Jönsson, B.
Olesen, J.
Allgulander, C.
Alonso, J.
Faravelli, C.
Fratiglioni, L.
Jennum, P.
Lieb, R.
Maercker, A.
van Os, J.
Preisig, M.
Salvador-Carulla, L.
Simon, R.
Steinhausen, H.C.
author_facet Wittchen, H.U.
Jacobi, F.
Rehm, J.
Gustavsson, A.
Svensson, M.
Jönsson, B.
Olesen, J.
Allgulander, C.
Alonso, J.
Faravelli, C.
Fratiglioni, L.
Jennum, P.
Lieb, R.
Maercker, A.
van Os, J.
Preisig, M.
Salvador-Carulla, L.
Simon, R.
Steinhausen, H.C.
author_sort Wittchen, H.U.
title The size and burden of mental disorders and other disorders of the brain in Europe 2010.
title_short The size and burden of mental disorders and other disorders of the brain in Europe 2010.
title_full The size and burden of mental disorders and other disorders of the brain in Europe 2010.
title_fullStr The size and burden of mental disorders and other disorders of the brain in Europe 2010.
title_full_unstemmed The size and burden of mental disorders and other disorders of the brain in Europe 2010.
title_sort size and burden of mental disorders and other disorders of the brain in europe 2010.
publishDate 2011
url https://doi.org/10.1016/j.euroneuro.2011.07.018
https://serval.unil.ch/notice/serval:BIB_78A8797CC5B2
long_lat ENVELOPE(63.761,63.761,-67.513,-67.513)
geographic Daly
Norway
geographic_facet Daly
Norway
genre Iceland
genre_facet Iceland
op_source Serveur académique Lausannois
European Neuropsychopharmacology, vol. 21, no. 9, pp. 655-79
op_relation doi:10.1016/j.euroneuro.2011.07.018
urn:issn:0924-977X
10670/1.2akzd0
https://serval.unil.ch/notice/serval:BIB_78A8797CC5B2
op_rights undefined
op_doi https://doi.org/10.1016/j.euroneuro.2011.07.018
container_title European Neuropsychopharmacology
container_volume 21
container_issue 9
container_start_page 655
op_container_end_page 679
_version_ 1766042872921980928